Mediscope_Logo_HighRes.png (2)
NordiQC_logo1-1
OIP
3099

NordiQC IHC Workshop

in Aotearoa NZ

15-16 May 2026

Venue: Pullman Hotel

Corner Waterloo Quadrant, & Princes Street Auckland 1010

 

 

Mediscope International Ltd. is hosting 2-days IHC workshop organized with Nordic immunohistochemical Quality Control (NordiQC) on the 15-16 May 2026 in Tāmaki Makarau Auckland.

NordiQC is a quality assurance program provider based in Aalborg, Denmark specialising in Immunohistochemistry (IHC). Their aim is to promote the quality of IHC and expand its clinical use by arranging schemes for immunohistochemical proficiency testing and providing examples of recommended protocols, tissue controls and other relevant information including descriptions of epitopes and technical protocol parameters. 

The event will be useful for medical laboratory scientists with experience in histology, immunohistochemistry, and pathologists/registrar in surgical pathology with special interest in the technical parts of IHC.

Event Programme

The official programme and speaker profile will be available at a later date (early 2026).

This event will be a compact event from NordiQC's annual workshop in Denmark and will be a good opportunity to connect and learn from the very best and have discussion with your peers.

This event has been registered for CPD points with the New Zealand Institute of Medical Laboratory Science (U/1722)

Presented by: Kristi Bøgh Anderson (MD) and Tanya Julio (BSc).

Aim of workshop: To give an update on basic and advanced immunohistochemical (IHC) methods applied in diagnostic pathology, particularly for the classification of the unknown primary tumour, breast and lung tumours. The seminar will particularly focus on

  • The impact of internal and external quality control
  • Understanding the technical test approach for IHC
  • Identification and handling of Technical and diagnostic pitfalls
  • Optimization of staining protocols
  • Planning and diagnostic use of antibody panels
  • Use of tissue controls
  • Application of IHC in the era of molecular testing
PROGRAMME

Speakers

Kristi Photo 5

Kristi Bøgh Anderson (MD)

Dr. Kristi Bøgh Anderson is a pathologist with a medical degree from the University of Tartu, Estonia, and a pathology specialization from Aalborg University Hospital in Denmark. She currently serves as a scientific associate and PhD fellow in the Nordic Immunohistochemical Quality Control (NordiQC) program—an international external quality assessment (EQA) scheme for immunohistochemsitry.

At NordiQC, she is an assessor for the general, breast and companion diagnostic modules. Together with NordiQC colleagues, she is involved in a range of scientific projects that provide technical, educational and consultancy support to pathology laboratories and industry partners worldwide.

Tanya Photo-2

Tanya Julio (BSc)

Tanya Julio is Technical Lead Specialist at Nordic immunohistochemical Quality Control (NordiQC) being an international external quality assessment (EQA) scheme for diagnostic pathology laboratories. 

At NordiQC, Tanya functions as scientific lead, assessor and data analyst in the NordiQC general module and breast module. Tanya is a regular lecturer at national and international immunohistochemical workshops, particularly in the field of protocol optimization and standardization. 

Tanya is educated as biomedical scientist and has worked intensively with immunohistochemistry for 13 years. 

Colin-2-2

Colin Tristram (MSc)

Colin Tristramhas over 25 years of experience in the development of in vitro diagnosticassays within tissue diagnostics, spanning antibody development through to thecreation of robust quality control materials. He holds a degree in MedicalMicrobiology from Newcastle University (UK) and a Master’s degree in CancerBiology.

His earlyresearch focused on HER2 biology, examining differences between internal andexternal receptor domains. This work led to the establishment of a panel ofcell lines for HER2 assessment that remains in use today by UK NEQAS ICC &ISH. In addition, Colin contributed to the development of monoclonal antibodiesat Novocastra Laboratories, which became part of Vision BioSystems andsubsequently Leica Biosystems. At Leica, he led innovation initiatives and thedevelopment of prognostic and companion diagnostic (CDx) projects.

Scientist Pricing

Current Pricing: Standard (01/02-31/03)

$375/Person (GST inclusive)
  • 2-day delegate package for 15th and 16th of May
  • Standard pricing (01/02 - 31/03): $375/Person
  • Late Pricing (01/04-14/05): $450/Person

Pathologist Pricing

Current Pricing: Standard (01/02-31/03)

$775/Person (GST inclusive)
  • 2-day delegate package for 15th and 16th of May
  • Standard pricing (01/02 - 31/03): $775/Person
  • Late Pricing (01/04-14/05): $850/Person

Registration

Please use the registration form below and fill out the registration details.

Policies

Refund Policy
  • Full Refund:
    • Available for cancellations made on or before 31 January 2026.
  • No Refunds:
    • Cancellations made on or after 1 February 2026 are not eligible for a refund under any circumstances.
Ticket Transfer
  • If you are unable to attend, you may transfer your ticket to another attendee at no additional cost.
  • To transfer a ticket:
    • Notify us at khoi@mediscope.co.nz with the new attendee’s details at least 48 hours before the event.
    • The original ticket holder is responsible for coordinating the transfer.
Travel & Accommodation

Ticket holders are responsible for:

  • Transport to and from the event.
  • Accommodation arrangements.
  • Relevant insurance coverage (including travel and health insurance).
For questions or enquiries, please contact Khoi Phan - AP Product Manager at Khoi@mediscope.co.nz
 
Mediscope International Limited.
 6/22 Highgate Parkway, Silverdale 0932, Auckland
+64 9 4210368 / 0800 840 010
Mediscope_Logo_HighRes.png (2)